Skip to content

The Relationship Between VDR Gene Polymorphism and Children's Physical and Intellectual Development

Multi-Center Clinical Study on the Relationship Between Vitamin D Receptor Gene Polymorphism and Children's Physical and Intellectual Development

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03742310
Acronym
RVDRGPCPID
Enrollment
500
Registered
2018-11-15
Start date
2019-01-01
Completion date
2021-03-01
Last updated
2018-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development, Child

Keywords

Vitamin D Receptor gene, physical development, intelligent development

Brief summary

This study was used to determine the relationship between vitamin D receptor gene polymorphism and children's physical and intellectual development, further adjust the doses of vitamin D supplementation after birth, and provide individualized vitamin D and calcium supplements.

Detailed description

High risk children aged 0-3 years old who visited the pediatrics clinic and ward of the first affiliated hospital of Xi'an Jiaotong university and other cooperative hospitals from 2018 to 2020 were randomly selected. Personal information of the children and parents who were enrollment was collected by questionnaire survey and a follow-up file was established. 500 to 1,000 people are planned to participate in the study, were randomly divided into research group and the control group. Then collect the sample(saliva) of children to examine Vitamin D Receptor(VDR) genotype, according to results, divide the research group into high, medium and low risk, given individual vitamin D and calcium supplement. Monitor the children's weight, body length, head circumference, the Neonatal Behavioral Assessment Scale(NBAS), bailey rating scale respectively, up to 3 years old. All sample analyses were performed by the Gene Medical Laboratory. Laboratory personnel were blinded to mother and infant outcomes.

Interventions

DRUGVitamin D

Vitamin D is essential for healthy bones, and to control the amount of calcium in our blood.It is important at every stage of life, but especially for rapidly growing infants and teenagers and for pregnant and breastfeeding women.

Sponsors

Xian Children's Hospital
CollaboratorOTHER_GOV
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Years
Healthy volunteers
Yes

Inclusion criteria

* infant age from 0 to 3 years old * enjoy good health, there is no history of specific diseases

Exclusion criteria

* this time or always exists serious lung infection, or with nervous system disease, kidney disease, malignant tumor, etc * has bone metabolic diseases or other genetic metabolic disease * taking affect bone metabolism of drugs for a long time

Design outcomes

Primary

MeasureTime frameDescription
body heightFrom date of randomization until the date of three year-oldWe will use the baby scale to measure infant body height
body weightFrom date of randomization until the date of three year-oldWe will use the baby scale to measure infant body weight
head circumferenceFrom date of randomization until the date of three year-oldWe will use the tape to measure infant head circumference

Countries

China

Contacts

Primary ContactHui Li, PHD,MD
huili@mail.xjtu.edu.cn+8618991232133
Backup ContactZhongliang Zhu, PHD
zlzhu@mail.xjtu.edu.cn+8613991289992

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026